American Water Works heads into its July 30 earnings with analyst momentum building, short sellers in modest retreat, and options traders leaning more bullish than they have in months.
The clearest story this week is on the Street. JP Morgan's Jeremy Tonet raised his price target from $138 to $147 on July 8, maintaining a Neutral rating — a notable move given it comes just three weeks before the next earnings print. UBS also lifted its target, bumping from $140 to $150 earlier in the week while holding its Buy rating. Both actions follow UBS's May upgrade from Neutral to Buy, which itself came as the stock was finding its footing after a soft spring. The mean consensus target now rests at $137.91, slightly below the current price of $134.82 — though the two bullish target lifts this week suggest that gap is closing. Barclays remains the lone bear, maintaining Underweight with a $124 target. BofA and Wells Fargo sit in the neutral camp. The direction of travel on the Street is modestly constructive: the big moves are upgrades and target raises, not cuts.
Short positioning tells a supportive rather than alarming story. At 5.2% of the free float, short interest sits in meaningful but not extreme territory — and the trend is lower. It has fallen roughly 10% over the past month, retreating from a peak near 12 million shares in mid-June to just above 10.2 million. Borrowing costs remain negligible at 0.50%, barely changed on the week. Availability is loose at around 412% — meaning there are more than four shares available to borrow for every one already shorted — and that figure has actually widened slightly over the past week. There is no evidence of a squeeze dynamic or forced covering; this looks like a gradual, organic reduction in bearish positioning as the stock has re-rated higher.
Options traders have shifted to a noticeably more bullish lean. The put/call ratio has dropped to 0.51, about one standard deviation below its 20-day average of 0.60. That's close to the 52-week low of 0.44 — the most call-heavy the options market has been all year. The shift is sharp: as recently as late June, the PCR was running above 0.85 during a period of broader equity uncertainty. The reversal over the past two weeks mirrors the stock's own recovery, which is up 8.3% over the past month and 2.5% on the week.
Wellington Management stands out among institutional holders, reporting a net addition of nearly 3.9 million shares as of May 31 — a meaningful build at a firm of that size. BlackRock also added close to 990,000 shares through June 30, reinforcing the impression that large passive and active holders are comfortable with AWK at current levels. The ORTEX short score sits near 49, roughly mid-range, consistent with the mixed but improving picture across the lending and options data.
The valuation picture has drifted higher with the price. The price-to-earnings multiple has expanded by about 1.4 turns over the past 30 days to 21x, and price-to-book has moved up roughly 7% over the same period. Neither is stretched by water utility standards, but the stock's dividend score ranks in the 99th percentile across the universe — a reminder that AWK's primary appeal is income and regulatory predictability rather than growth optionality. The forward EPS growth factor score ranks at the 76th percentile, suggesting the earnings delivery story remains intact heading into Q2 results on July 30.
The next read will be whether AWK's Q2 print — following two consecutive quarters where the stock fell 1–3% on the day — finally breaks that pattern, with the Street and positioning both more constructively positioned than they were six weeks ago.
See the live data behind this article on ORTEX.
Open AWK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
